Related Experiment Video
Updated: Jun 19, 2025

05:49
Protein Engineering by Yeast Surface Display
Published on: November 29, 2024
1.2K
Rapidly Inducible Yeast Surface Display for Antibody Evolution with OrthoRep
Alexandra M Paulk1,2,3, Rory L Williams2,3, Chang C Liu2,3,4,5
1Program in Mathematical, Computational and Systems Biology, University of California, Irvine, California 92697, United States.
ACS Synthetic Biology
|July 25, 2024
Summary
We improved the Autonomous Hypermutation Yeast Surface Display (AHEAD) technology for faster antibody evolution. A new synthetic estrogen-inducible system significantly speeds up antibody display on yeast cells, accelerating antibody discovery.
Area of Science:
- Biotechnology
- Molecular Biology
- Immunology
Background:
- Yeast surface display is a powerful tool for antibody engineering.
- The Autonomous Hypermutation Yeast Surface Display (AHEAD) platform rapidly generates potent antibodies.
- Current AHEAD systems rely on galactose induction, which can be slow (up to 48 hours).
Purpose of the Study:
- To enhance the AHEAD platform for faster antibody evolution.
- To investigate a novel synthetic β-estradiol-inducible system for antibody surface display.
- To improve the efficiency of antibody generation using yeast surface display.
Main Methods:
- Implementation of a synthetic β-estradiol-inducible gene expression system.
- Comparison of induction times between the new system and traditional galactose induction.
- Evaluation of the updated AHEAD platform in antibody evolution experiments.
Main Results:
- The synthetic β-estradiol-inducible system significantly accelerated antibody surface display.
- Faster induction was observed for both the updated AHEAD system and traditional yeast surface display.
- The updated AHEAD platform successfully drove rapid antibody evolution through multiple rounds.
Conclusions:
- A synthetic β-estradiol-inducible system offers a faster alternative for antibody display in yeast.
- This improvement enhances the AHEAD platform's efficiency for rapid antibody evolution.
- The updated AHEAD technology accelerates the generation of potent and specific antibodies.

